Curcumin and multiple health outcomes: critical umbrella review of intervention meta-analyses
Frontiers in Pharmacology · 05.06.2025 · 16
DOI: 10.3389/fphar.2025.1601204 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 05.06.2025. Verfasst von Qin Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
This review aimed to determine the therapeutic effects and safety of oral curcumin compared with other comparators for human health and wellbeing outcomes.
Methods
PubMed, Embase, and Cochrane Library were searched from their inception to 18 June 2024. The Assessment of Multiple Systematic Reviews-2 checklist, and Grading of Recommendations, Assessment, Development and Evaluation system were used to assess the methodological and evidence quality for each meta-analysis, respectively. The results are presented in a narrative review.
Results
We included 25 studies. The overall methodological quality was relatively poor, and there is considerable room for improvement. The findings suggest that curcumin has potentially positive effects on lipid profiles, blood pressure, inflammatory markers and oxidative stress, musculoskeletal diseases, emotional and cognitive function, ulcerative colitis, liver and kidney function, primary dysmenorrhea or premenstrual syndrome, rheumatoid arthritis, COVID-19, painful statues, and HR-QOL. However, for many diseases, the conclusions remain uncertain.
Conclusion
The available evidence suggests that curcumin is a safe medicinal agent that improves multiple clinical outcomes; however, the scientific quality of published studies needs to be improved.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
- Department of Oncology, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
- Department of Traditional Chinese Medicine Internal Medicine, Eye Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xu, Q., Lian, H., Zhou, R., Gu, Z., Wu, J., Wu, Y., & Li, Z. (2025). Curcumin and multiple health outcomes: critical umbrella review of intervention meta-analyses. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1601204
Vancouver
Xu Q, Lian H, Zhou R, Gu Z, Wu J, Wu Y, et al. Curcumin and multiple health outcomes: critical umbrella review of intervention meta-analyses. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1601204
BibTeX
@article{Xu2025,
author = {Xu, Qin and Lian, Hua and Zhou, Rui and Gu, Zhenzhen and Wu, Jiao and Wu, Yu and Li, Zhongyu},
title = {Curcumin and multiple health outcomes: critical umbrella review of intervention meta-analyses},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1601204}
}
EUVIMED